The problem in your portfolio
Early-stage hardtech, bio, and food startups often hit a wall between lab and market. Regulatory confusion, missing assays, or misformatted filings freeze investor capital and burn runway.
What the cohort receives
- 5 individual regulatory roadmap reports — line-by-line audit of lab data (Certificates of Analysis), labeling claims, and agency jurisdiction (FDA, EPA, USDA, State Ag).
- Missing assay identification — early detection of out-of-bound variables or missing heavy metal / microbial panels.
- Executive summary for program directors — show board members and funders how TA budget de-risked portfolio companies.
Procurement
Single $5,000 purchase covering a five-company cohort. Same DTC SKU math Trellis uses for founders — no separate institutional product line.